Background Despite their effectiveness and ease of use, medication errors have been
reported to be highly prevalent with direct-acting oral anticoagulants (DOAC). Aim The aim …

Abstract Background Direct oral anticoagulants (DOACs) have become preferable for the
management of thromboembolic events. Recent publications have however identified high …

Background For more than a decade, direct oral anticoagulants (DOACs) have been
approved in clinical practice for multiple indications such as stroke prevention in non …

Purpose This study aimed to estimate the prevalence, contributory factors, and severity of
medication errors associated with direct acting oral anticoagulants (DOACs). Methods A …

Abstract Background Direct oral anticoagulants (DOACs) have revolutionised anticoagulant
pharmacotherapy. However, DOAC-related medication incidents are known to be common …

Stroke and venous thromboembolism continues to be a major cause of morbidity and
mortality worldwide. The use of anticoagulation therapy has proven effective in the …

Abstract Background Direct oral anticoagulants (DOACs) are considered high‐risk
medications and pose a serious threat to patients if mismanaged. Furthermore, medication …

ABSTRACT Introduction Direct oral anticoagulants (DOACs) are considered high risk
medicines and are frequently associated with medication errors. The nature of incidents and …

Medication errors involving oral anticoagulants have led to serious adverse events,
including hemorrhage, treatment failures leading to thromboembolic events, and death. This …

Aims Anticoagulants represent a main source of medication errors (MEs) and complications
that have catastrophic implications, posing an obligation on health care providers to assess …